- Tytuł:
- Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study
- Autorzy:
- Źródło:
- Clinical and Experimental Medicine. 23(8):5413-5422
Czasopismo naukowe